AIM: the cash flow

MyFinsight

For the quarter ending 2025-09-30, AIM had $1,871K increase in cash & cash equivalents over the period.

Cash Flow	2025-09-30	2025-06-30
Loss (gain) on sale of marketable investments	-	18
Net loss	-3,284	-6,499
Depreciation of property and equipment	9	19
Abandonment and expiration of patents and trademark rights	82	615
Amortization of patent, trademark rights	45	94
Non-cash lease expense	-59	-81
Equity-based compensation	0	60
Gain on sale of marketable securities	17	-
Amortization of financial obligation	69	183
Change in fair value of warrants	-670	-
Loss on issuance of warrants	-3,977	0
Non-cash gain on settlement of liability	-3,041	-
Prepaid expenses and other current assets	-24	-9
Lease liability	-56	-78
Funds receivable from new jersey net operating loss	-	0
Other assets	11	-761
Accounts payable	-2,570	914
Accrued expenses	287	-33
Net cash used in operating activities	-5,079	-3,892
Proceeds from sale of marketable securities	296	2,026
Purchase of marketable securities	0	91
(purchase) abandonment of patent and trademark rights	0	283
Net cash provided by investing activities	296	1,652
Proceeds from issuance of common stock and warrants	7,314	-
Proceeds from sale of stock, net of issuance costs	-398	765
Proceeds from note payable, net of issuance costs	0	250
Repayment of debt with cash	660	-
Proceeds from issuance of equity warrants	-	0
Proceeds from equity line of credit	398	-
Net cash provided by financing activities	6,654	1,015
Net increase (decrease) in cash and cash equivalents	1,871	-1,225
Cash and cash equivalents at beginning of period	1,701	-
Cash and cash equivalents at end of period	2,347	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.